Private Brand Head Cures For All!

\"\"Private Brand pharmaceutical giant Perrigo today announced that it has launched Naproxen Sodium Soft Gels. This would not normally be news on this site, as I typically discuss brand and brand building and let manufacturer news fall to the trade magazines. This one just falls into the personal realm I am a huge fan of the Soft Gel deliver system and waited anxiously for many years for it to become available, this latest announcement makes both Ibuprofen and Naproxen Sodium available in Soft Gels at a great price. Headache sufferers rejoice.

The product is the generic equivalent of Bayer HealthCare\’s Aleve Liquid Gels, 220mg, an OTC analgesic.  Aleve Liquid Gels had sales of approximately $80 million, as measured by Information Resources, Inc. Perrigo believes it is the first to market a Private Brand version of this product.

Perrigo\’s Chairman and CEO Joseph C. Papa stated, \”This approval is another example of Perrigo\’s commitment to bring new products to market. Perrigo is working every day to make quality healthcare more affordable.\”



Do Brands Stil Matter In A Private Brand World?

\"\"The core objective of this report is to examine the current state of private label products within the global packaged food industry, including any impact that continued global economic uncertainty -or its immediate aftermath -is having on the performance of retailers‟ own brands.

While the recent global economic downturn had a comparatively minimal impact on packaged food sales, continued economic anxiety, largely stemming from ongoing concerns over sovereign debt levels in Europe, mean future industry growth prospects are far from guaranteed.

In turn, many consumers remain very price sensitive and are looking for bargains and perceived \”value for money\” wherever they can. This is creating more space for private label packaged food items to maneuver.

Private label packaged food offerings are also becoming more sophisticated and up market. Not only are some private label food items attempting to leverage a more premium-minded cachet, and thus leading to a tiered pricing strategy between traditional budget ranges and more expensive gourmet options, retailers are also looking to add value in other ways, both to compete more effectively against brands looking to differentiate themselves and to boost their own margins. As such, recent years have seen private label packaged food tap into driving industry trends such as health and wellness (better-for-you food such as reduced salt/fat/etc., functional food, naturally healthy food) and ethical positioning (organic, fair trade‟, free-range, sustainable, etc.).

In addition to providing a global overview of private label packaged food market performance, the report also provides insight on benefits and shortcomings inherent to private label, retail market performance by geographic region and product category, key trends and developments and global prospects and opportunities.

The report does not claim to be comprehensive, focusing on key industry categories, but rather seeks to offer high-level insight into key changes in the market at a time of continued macroeconomic instability.

The recent economic downturn has benefited private label food. Consumers have been encouraged to try the relatively cheaper offerings and have invariably continued to purchase them even as economic conditions have begun to improve.

In addition to competing on price, retailers have also continued to work aggressively to improve their private label packaged food ranges in an effort to transcend the stigma of being cheap and poor quality imitations of branded items.

Retailers are acting in a more brand-orientated manner and introducing innovative and added-value packaged food including functional and ethical products (organic, ‘fair trade\’, etc.). This is boosting the image of private label food among consumers.

In line with this greater focus on adding value, retailers are also starting to segment their private label ranges by price point and are implementing a tiered pricing strategy distinguishing economy lines from their premium/value-added counterparts.

Despite recent advancements, private label packaged food still struggles with a low-quality image, especially in sectors such as baby food and confectionery where brands have established reputations. Trust is a major barrier to wider acceptance.

Retail consolidation has driven private label\’s overall packaged food retail value share, but in emerging markets such as Eastern Europe a general lack of modern grocery channels will make it harder to penetrate and ultimately win consumer acceptance.

The future growth of private label packaged food will largely depend on the ability of both retailers and their contract suppliers to remain at the forefront of innovation and to further build up consumer trust, while still keeping prices competitive.

Should this continue, opportunities in previously off-limit sectors such as baby food should arise. This is already happening in major markets such as the USA, where private label consumer healthcare manufacturer Perrigo has entered the baby food market.

Do Brands Still Matter? – Focus on Private Label Packaged Food market report offers a comprehensive guide to the size and shape of the market at an international level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Learn More & Order the Report


Buy Private Brand Stock Before the Lemmings Raise Their Numbers.

I have included Mad Money host Jim Cramer in a post before and it illicited a significant response both here and in LinkedIn groups, so it is interesting to hear him push Private Brand HBC manufacturer Perrigo. Love him or hate him, Cramer is polarizing and I think he is write Perrigo’s stock has “much more room to run,” he said, “especially if you can buy it before the deal closes and all the lemming analysts raise their 2011 numbers.”

Over-the-counter drugmaker Perrigo [PRGO 59.00 — UNCH (0) ] just made a “smart takeover,” Cramer said, that extends its reach into yet another aisle in your local pharmacy. He had already recommended the stock in February – it’s up 27% since – but this new deal “makes the story even more compelling.”

Perrigo was largely known as the world’s largest manufacturer of over-the-counter private-label drugs, but the company also dabbles in generic drugs and active pharmaceutical ingredients. Then on March 23, management announced they were buying PBM, a privately held maker of store-brand infant formula and baby food for $808 million. Wall Street immediately blessed the deal, taking PRGO up 12% in just one day.